Hershel Safer, formerly a research scientist at Tel Aviv-based Compugen, has been tapped to head the bioinformatics department at Zetiq Technologies, a Rehovot, Israel-based biotechnology company developing non-cytotoxic anti-cancer drugs.
Morphochem of Munich, Germany, has appointed Eric Eastman to the newly created position of president of Morphochem Inc. He will also run the company’s research facility in Monmouth Junction, NJ. Eastman was previously senior vice president and CTO at Gaithersburg, Md.-based Gene Logic, where he managed the company’s R&D activities and its technology portfolio.
Lion Biosciences said it has appointed Martin Hollenhorst as the company’s new CFO. Hollenhorst, who most recently worked as a freelance management consultant in Washington, DC, will join the Heidelberg, Germany-based company on April 1. Hollenhorst’s experiences include serving as CEO of ANN Systems ASA, a German-American software company. He replaces Lion’s former CFO Klaus Sprockamp, who was lost in the Sept. 11 attacks on the World Trade Center in NewYork.